Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
Lifecore Biomedical (NASDAQ: LFCR) will participate in the William Blair 46th Annual Growth Stock Conference in Chicago.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lifecore Biomedical (NASDAQ: LFCR) will participate in the William Blair 46th Annual Growth Stock Conference in Chicago. The event runs from June 2-4, 2026 at the Loews Chicago Hotel.
CEO Paul Josephs and CFO Ryan Lake will attend and hold investor meetings.
Details
News Market Reaction – LFCR
On May 21, the day this news came out, LFCR closed 8.97% above the previous close.
Data tracked by StockTitan Argus for the May 21 session.
Key Figures
- Conference edition
- 46th Annual
- William Blair Growth Stock Conference
- Conference dates
- June 2–4, 2026
- William Blair 46th Annual Growth Stock Conference
Historical Context
-
Weak Q1 2026 revenue and continued net loss with reaffirmed guidance.
-
Announcement of timing and webcast details for upcoming Q1 2026 results.
-
5,000-share RSU inducement grant to a new hire under Nasdaq Rule 5635(c)(4).
-
Participation in American Biomanufacturing Summit to highlight injectable CDMO services.
-
18,500-share RSU inducement grant for a new employee under Nasdaq Rule 5635(c)(4).
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
contract development and manufacturing organization technical
cdmo technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHASKA, Minn., May 21, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the William Blair 46th Annual Growth Stock Conference. The conference will take place June 2-4, 2026, in Chicago, IL.
Details regarding Lifecore’s participation are as follows:
- William Blair 46th Annual Growth Stock Conference
Details: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in investor meetings.
Conference Dates: June 2-4, 2026
Location: Loews Chicago Hotel, Chicago, IL
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
Contact Information:
Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com
Jennifer Arcure (Media)
917-603-0681
jarcure@vidasp.com
Lifecore Biomedical
Ryan D. Lake (CFO)
952-368-6244
ryan.lake@lifecore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.